Ondansetron and metoclopramide fail to prevent vomiting secondary to ultra-high-dose cisplatin-carboplatin chemotherapy

Obstet Gynecol. 1994 Sep;84(3):483-4.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects*
  • Carboplatin / administration & dosage
  • Cisplatin / administration & dosage
  • Female
  • Humans
  • Metoclopramide / therapeutic use*
  • Ondansetron / therapeutic use*
  • Research Design
  • Vomiting / chemically induced*
  • Vomiting / prevention & control*

Substances

  • Ondansetron
  • Carboplatin
  • Metoclopramide
  • Cisplatin